HSPB1 and oligodendroglioma: They identified RNA binding protein NOVA-1 (NOVA1) to be a marker distinguishing astrocytoma with oligodendrogliomas and heat shock protein beta 1 (HSPB1) as a predictive marker for poor prognosis for GBM15.